RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Marcos Ramos-Benitez to Adult

This is a "connection" page, showing publications Marcos Ramos-Benitez has written about Adult.
Connection Strength

0.160
  1. Caro-Rivera LM, Malavez-Cajigas S, Lacourt-Ventura M, Rivera-Torres AP, Marcano-Jim?nez DE, L?pez-Colon P, Mu?iz-Hern?ndez J, Rivera-Jim?nez E, Egozcue-Dionisi M, Rom?n-Carlo R, De Jes?s-Rojas W, Ramos-Ben?tez MJ. Age-related neutrophil activation in Hermansky-Pudlak Syndrome Type-1. Orphanet J Rare Dis. 2025 May 12; 20(1):226.
    View in: PubMed
    Score: 0.074
  2. Arif M, Basu A, Zuo BLG, Zuo MXG, O'Brien KJ, Pommerolle L, Caro-Rivera LM, De Jesus-Rojas W, Ramos-Benitez MJ, Behan M, Introne WJ, Frost G, Moaddel R, Gahl WA, Malicdan MCV, Gochuico BR, Cinar R. Choline and CCL22 Are Prognostic Blood Biomarkers for Hermansky-Pudlak Syndrome Pulmonary Fibrosis. Am J Respir Cell Mol Biol. 2026 Jan 01; 74(1):80-93.
    View in: PubMed
    Score: 0.019
  3. Rom?n-R?os G, Rosario-Ortiz G, Ramos-Benitez MJ, Mosquera RA, De Jes?s-Rojas W. RSPH4A-PCDx: An Index to Predict Lung Function Decline in Primary Ciliary Dyskinesia. Adv Respir Med. 2025 Aug 02; 93(4).
    View in: PubMed
    Score: 0.019
  4. De Jes?s-Rojas W, Reyes-Pe?a L, Mu?iz-Hernandez J, Mena-Ventura R, Camareno-Soto G, Rosario-Ortiz G, Ramos-Benitez MJ, Egozcue-Dionisi M, Rivera-Jimenez E, Rom?n-Carlo R. Application of Forced Oscillation Technique in Assessing Pulmonary Fibrosis in Hermansky-Pudlak Syndrome. Adv Respir Med. 2024 Oct 24; 92(6):444-451.
    View in: PubMed
    Score: 0.018
  5. Strich JR, Tian X, Samour M, King CS, Shlobin O, Reger R, Cohen J, Ahmad K, Brown AW, Khangoora V, Aryal S, Migdady Y, Kyte JJ, Joo J, Hays R, Collins AC, Battle E, Valdez J, Rivero J, Kim IH, Erb-Alvarez J, Shalhoub R, Chakraborty M, Wong S, Colton B, Ramos-Benitez MJ, Warner S, Chertow DS, Olivier KN, Aue G, Davey RT, Suffredini AF, Childs RW, Nathan SD. Fostamatinib for the Treatment of Hospitalized Adults With Coronavirus Disease 2019: A Randomized Trial. Clin Infect Dis. 2022 08 24; 75(1):e491-e498.
    View in: PubMed
    Score: 0.015
  6. Vannella KM, Oguz C, Stein SR, Pittaluga S, Dikoglu E, Kanwal A, Ramelli SC, Briese T, Su L, Wu X, Ramos-Benitez MJ, Perez-Valencia LJ, Babyak A, Cha NR, Chung JY, Ylaya K, Madathil RJ, Saharia KK, Scalea TM, Tran QK, Herr DL, Kleiner DE, Hewitt SM, Notarangelo LD, Grazioli A, Chertow DS. Evidence of SARS-CoV-2-Specific T-Cell-Mediated Myocarditis in a MIS-A Case. Front Immunol. 2021; 12:779026.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support